Type I IFN signaling blockade by a PASylated antagonist during chronic SIV infection suppresses specific inflammatory pathways but does not alter T cell activation or virus replication

Chronic activation of the immune system in HIV infection is one of the strongest predictors of morbidity and mortality. As such, approaches that reduce immune activation have received considerable interest. Previously, we demonstrated that administration of a type I interferon receptor antagonist (I...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:PLoS pathogens Ročník 14; číslo 8; s. e1007246
Hlavní autori: Nganou-Makamdop, Krystelle, Billingsley, James M., Yaffe, Zachary, O’Connor, Gregory, Tharp, Gregory K., Ransier, Amy, Laboune, Farida, Matus-Nicodemos, Rodrigo, Lerner, Andrea, Gharu, Lavina, Robertson, Jennifer M., Ford, Mandy L., Schlapschy, Martin, Kuhn, Nadine, Lensch, Alexandra, Lifson, Jeffrey, Nason, Martha, Skerra, Arne, Schreiber, Gideon, Bosinger, Steven E., Douek, Daniel C.
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States Public Library of Science 01.08.2018
Public Library of Science (PLoS)
Predmet:
DNA
HIV
RNA
ISSN:1553-7374, 1553-7366, 1553-7374
On-line prístup:Získať plný text
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Buďte prvý, kto okomentuje tento záznam!
Najprv sa musíte prihlásiť.